Supernus Pharmaceuticals Snaps Up Beleaguered Sage Therapeutics

Supernus Pharmaceuticals Snaps Up Beleaguered Sage Therapeutics · Investor's Business Daily

In This Article:

Supernus Pharmaceuticals agreed Monday to buy beleaguered biotech Sage Therapeutics in a deal that bolsters its nonpsychiatric portfolio.